Findings from CONFIRM - a large real-world evidence study - compared the effectiveness of Tresiba injections versus insulin glargine U300, marketed as Toujeo and sold by Sanofi. The study included ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback